TY - JOUR
TI - Inotuzumab ozogamicin for acute lymphoblastic leukaemia
J2 - Aust Prescr
JF - Australian Prescriber
PY - 2019
ET - 2019/06/17
VL - 42
SP - 141
EP - 142
DO - 10.18773/austprescr.2019.046
LA - eng
UR - https://australianprescriber.tg.org.au/articles/inotuzumab-ozogamicin-for-acute-lymphoblastic-leukaemia.html
KW - Besponsa
KW - inotuzumab ozogamicin
KW - acute lymphoblastic leukaemia
PB - Therapeutic Guidelines Ltd
SN - 1839-3942
ER -